The biotech sector is one of the market’s most dynamic and fastest-growing industries today. If you’ve been keeping an eye on the space, you may wonder which biotechnology stocks are worth your attention and money. There are numerous biotech stocks to choose from, but not all have staying power as long-term investments. Stocks with solid fundamentals and operating in sectors with a lot of growth potential can provide excellent returns for investors. Let us look closely at top biotech stocks to buy now and hold for the longer term.
Abcam (ABCM)
Abcam is a global biotechnology company that develops and manufactures life science research products. The company’s research products include antibodies, proteins, and other biomolecules used in various research, diagnostic, and drug discovery applications. Abcam’s products are used in multiple research areas, including immunology, neuroscience, oncology, stem cells, and genetic research. In addition, the company’s products are used at various new medicines’ discovery and development stages, including preclinical and early-stage clinical trials. Abcam’s customers include pharmaceutical companies, academic research institutions, biotechnology companies, contract research organizations, and other end users. Abcam has a vast distribution network across North America, Europe, Asia, Australia, and South America. In addition, the company has a strong presence in the United States, Europe, China, and India. Abcam is currently trading at a market capitalization of $3.37 billion. The stock has a dividend yield of 2.47%.
Gossamer Organic (GOSS)
Gossamer Organic is a manufacturer of organic cotton and hemp fabric. The company’s products are used in the apparel and textile industries. Gossamer Organic’s hemp fabrics are used in apparel, accessories, and furniture, while its organic cotton fabrics are used in clothing, bedding, and home decor. Customers use the company’s products in various industries, including women’s, men’s, and children’s apparel, footwear, accessories, home textiles, and bedding. Gossamer Organic currently has a market capitalization of $1.97 billion. The stock has a dividend yield of 1.89%.
Amicus Therapeutics (FOLD)
Amicus Therapeutics is a biopharmaceutical company discovering and developing drugs to treat rare and severe diseases. The company’s products treat rare diseases, including rare genetic diseases, neuromuscular diseases, and endocrine diseases. Amicus Therapeutics’ lead drug is FOLOTIN, an oral enzyme replacement therapy (ERT) indicated for patients with Fabry disease. The drug is approved in the United States, Europe, Japan, China, and South Korea. Fabry disease is an inherited genetic disorder that causes a buildup of certain fats called glycosphingolipids. These fats are found in all body cells and are needed for normal body functions, such as manufacturing and regulating hormones, immunity, and blood clotting. Amicus Therapeutics has a market capitalization of $8.29 billion. The stock has a dividend yield of 3.57%.
Itasca (ERAS)
Itasca is a specialty biopharmaceutical company that develops and commercializes therapeutics for rare diseases. The company’s lead product is mesalazine, an aminoglycoside antibiotic used to treat cystic fibrosis patients with Pseudomonas aeruginosa infections. In addition, Erica’s product pipeline includes mepolizumab; an investigational monoclonal antibody studied in a Phase III trial to treat patients with hereditary hemochromatosis. Erica’s products treat rare diseases, including cystic fibrosis, hereditary hemochromatosis, and chronic bacterial infections. In addition, the company’s products are used in pre- or post-surgery tree-of cystic fibrosis patients or treating chronic bacterial infections. Itasca is currently trading at a market capitalization of $1.84 billion. The stock has a dividend yield of 1.44%.
Conclusion
Choosing the right supplies is essential for biotechnology stocks and avoiding buying high-risk, high-reward biotech stocks. Investing in high-quality, established biotech companies with strong fundamentals can be a great way to generate long-term returns in the sector. Biotech companies should have strong product pipelines and robust growth, which can help them survive industry volatility and fluctuations in the stock price. We recommend investing in Abcam, Gossamer Organic, Amicus Therapeutics, and Itasca.
Read More: Top Biotechnology Stocks to Buy Now and Hold